Veracyte | VCYT - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agenus USD 38.52M 3.2M 2026-03
Agilent USD 281.97M 252K 2026-06
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
Bruker USD 152.35M 130K 2026-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Illumina USD 151.3M 607K 2026-06
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Laboratory Of America USD 80.9M 1.4M 2026-06
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06
Siemens EUR 762.74M 0 2026-06
Sonic Healthcare AUD 4.15B 467K 2024-12
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Veracyte USD 79.79M 1000 2026-06
Waters USD 98.19M 20K 2026-06